| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/22/1999 | WO1999019478A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 04/22/1999 | WO1999019477A1 Cadherin derived growth factor and the application thereof |
| 04/22/1999 | WO1999019476A2 NON-MAMMALIAN MESODERM INDUCTION EARLY RESPONSE (nm-MIER) GENE FAMILY |
| 04/22/1999 | WO1999019475A2 Mammalian mesoderm induction early response (m-mier) gene family |
| 04/22/1999 | WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | WO1999019470A2 Gfp-annexin fusion proteins |
| 04/22/1999 | WO1999019469A1 Porcine stem cells comprising a marker under an oct-4 promoter |
| 04/22/1999 | WO1999019468A1 Mammals lacking expression of osteoprotegerin |
| 04/22/1999 | WO1999019457A1 Regulators of ucp3 gene expression |
| 04/22/1999 | WO1999019359A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | WO1999019357A2 Cell regulatory genes, encoded products, and uses related thereto |
| 04/22/1999 | WO1999019356A1 Trivalent thrombin inhibitor |
| 04/22/1999 | WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | WO1999019353A1 Human progastrin for the diagnosis and treatment of pathological conditions of the gastrointestinal tract |
| 04/22/1999 | WO1999019352A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids |
| 04/22/1999 | WO1999019351A1 Novel npy family member |
| 04/22/1999 | WO1999019350A1 Use of elicitins as lipid carriers |
| 04/22/1999 | WO1999019349A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | WO1999019348A1 Laminins and uses thereof |
| 04/22/1999 | WO1999019339A1 53 human secreted proteins |
| 04/22/1999 | WO1999018995A1 Immunogenic peptides from the hpv e7 protein |
| 04/22/1999 | WO1999018994A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | WO1999018990A1 The il-1 receptor related protein 3 (il-1rrp3) |
| 04/22/1999 | WO1999018989A1 F-box proteins and genes |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018986A1 Method for inhibiting the binding of low density lipoprotein to blood vessel matrix |
| 04/22/1999 | WO1999018983A1 Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease |
| 04/22/1999 | WO1999018976A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | WO1999018945A1 Method of building and maintaining bone |
| 04/22/1999 | WO1999018909A2 Interferon-gamma regulatory factors |
| 04/22/1999 | WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | WO1999006561A3 Chemokine receptor ccr8 dna and uses thereof |
| 04/22/1999 | WO1999006552A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN BRAIN |
| 04/22/1999 | WO1999004806A9 Methods and compositions for inhibiting angiogenesis |
| 04/22/1999 | WO1999004024A3 Nucleotide sequences of genes encoding sink proteins and uses thereof for improving the nutritional quality of feeds |
| 04/22/1999 | WO1999004011A3 Hiv-1 group o antigens and uses thereof |
| 04/22/1999 | WO1999004007A8 Increasing production of proteins in gram-positive microorganisms |
| 04/22/1999 | WO1999003981A8 Nucleic acid expression constructs incorporating a heterologous intron whose natural position is within the 5'untranslated region of its gene |
| 04/22/1999 | WO1999003501A9 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 04/22/1999 | WO1999002693A3 Microbial swollenin protein; dna sequences encoding such swollenins and method of producing such swollenins |
| 04/22/1999 | WO1999001565A9 Method for increasing secretion of proteins in eukaryotic host cells |
| 04/22/1999 | WO1999000424A3 Antibodies and other binding molecules specific for hepatitis b viral antigens |
| 04/22/1999 | WO1998058957A3 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/22/1999 | WO1998053068A9 Smad7 and uses thereof |
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998047921A9 Mammalian cytokines; related reagents and methods |
| 04/22/1999 | WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 04/22/1999 | WO1998044788A9 Animal model for evaluation of vaccines |
| 04/22/1999 | WO1998036779A3 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/22/1999 | WO1998008934A9 Serum-free mammalian cell culture medium, and uses thereof |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | DE19745583A1 New actagardine derivatives with extra N-terminal amino acid |
| 04/22/1999 | DE19745443A1 Diagnostic polyclonal antiserum specific for prion protein |
| 04/22/1999 | CA2696653A1 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2308121A1 Mammals lacking expression of osteoprotegerin |
| 04/22/1999 | CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2307328A1 Cell division regulators |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306451A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2306344A1 Method of building and maintaining bone |
| 04/22/1999 | CA2306228A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | CA2306206A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305817A1 Methods for obtaining plant varieties |
| 04/22/1999 | CA2305713A1 Apo-3 ligand |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2305693A1 Mammalian mesoderm induction early response (m-mier) gene family |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2304169A1 Laminins and uses thereof |
| 04/22/1999 | CA2303844A1 Regulators of ucp3 gene expression |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0909817A1 Uses of gro genes and proteins |
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909815A2 Dna sequence conferring cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909813A1 Totipotent hematopoietic stem cell receptors -flk-1 and flk-2, and their ligands |
| 04/21/1999 | EP0909765A2 Calcitonin analogues having increased hypocalcaemic activity in vivo |
| 04/21/1999 | EP0909564A1 Erythropoietin solution preparation |
| 04/21/1999 | EP0909388A2 Immunological assay for spongiform encephalopathies |
| 04/21/1999 | EP0909324A2 Toxins active against pests |
| 04/21/1999 | EP0909323A1 Helicobacter pylori bacterioferritin |
| 04/21/1999 | EP0909322A1 Antiviral ricin-like proteins |
| 04/21/1999 | EP0909321A2 Mammalian chemokine reagents |
| 04/21/1999 | EP0909320A1 CHEMOKINE beta-15 |
| 04/21/1999 | EP0909319A2 Growth arrest gene compositions and methods |
| 04/21/1999 | EP0909318A1 Human stem cell antigens, dna coding therefor and their use |
| 04/21/1999 | EP0909317A1 Composition and methods for modulating the length of telomeres |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909315A2 Cck-2, a receptor tyrosine kinase |
| 04/21/1999 | EP0909314A1 Plant sugar sensors and uses thereof |
| 04/21/1999 | EP0909313A1 Methods for creating transgenic animals |
| 04/21/1999 | EP0909312A1 Method for the production of polypeptides |
| 04/21/1999 | EP0909276A1 Purification of soluble laminin 5 |
| 04/21/1999 | EP0909275A1 Receptor derived peptides involved in modulation of response to ligand binding |